Million-Sample Multi-Omics Platforms

Clean the Sky - Positive Eco Trends & Breakthroughs

Ultima Genomics Supports Precure’s Large-Scale Dataset

Edited by Mursal Rahman — September 22, 2026 — Experience, Retail & Emerging
This article was written with the assistance of AI.
Ultima Genomics is supporting one of the largest million-sample multi-omics platforms through Precure, an initiative led by Mayo Clinic in partnership with Thermo Fisher Scientific. Precure will integrate whole-genome sequencing, proteomic information and longitudinal clinical data from one million biospecimens to identify biological signals that may appear before disease symptoms. Helix will generate sequencing data using Ultima’s UG200 platform, which can produce up to 60,000 whole genomes annually. AI and large-scale analytics will help researchers identify patterns across the combined datasets.

The project demonstrates how lower-cost, high-throughput sequencing can make population-scale biomedical research more practical. For Ultima Genomics, selection for the initiative validates the UG200’s potential for large research programs and strengthens its position in genomic infrastructure. The resulting dataset could also support researchers developing new diagnostics and therapeutics while creating opportunities for broader AI-driven precision medicine applications.

Image Credit: Ultima Genomics
Consumer Demand Drives Foldable and Multi-Screen Devices
Consumers are adopting foldable and multi-screen devices as they seek more versatile and pocketable screen options for enhanced mobility and functionality.
Question 1
Which of the following types of devices have you personally used in the past 12 months?
Select up to 8
Question 2
What are the main reasons you use or chose this type of device?
Select up to 3
Question 3
How likely would you be to choose a foldable or multi-screen device the next time you purchase a smartphone, tablet, or laptop?

Trend Themes

  1. Population-scale Multi-omics — Massive integrated datasets combining genomics, proteomics and clinical records create new pathways for earlier disease detection and preventive care models.
  2. Low-cost Genome Sequencing — Declining sequencing costs and higher throughput enable research programs to scale from niche cohorts to million-sample biomedical platforms.
  3. AI-driven Precision Medicine — Advanced analytics applied to longitudinal biological data reveal pre-symptomatic patterns that can reshape diagnostics, therapeutics and risk prediction.

Industry Implications

  1. Genomics — High-capacity sequencing infrastructure supports broader adoption of whole-genome analysis across clinical research and population health initiatives.
  2. Biotechnology — Large multi-omics repositories provide a foundation for discovering biomarkers, validating drug targets and accelerating therapy development.
  3. Healthcare Analytics — AI-enabled interpretation of complex patient datasets expands the role of predictive insights in personalized medicine and preventive healthcare.
6.7
Score
Popularity
Activity
Freshness